Tag: AIBased
Flare Therapeutics Presents Novel, AI-Based Method Identifying Luminal Subtype of Urothelial Cancer Supporting Lead Asset FX-909 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
– Approach has potential to identify patients likely to respond to PPARG inhibition through FX-909 –
– AI-powered, end-to-end learning model was deve [...]
Nasdaq receives SEC approval for AI-based trade orders
Nasdaq announced that the United States Securities and Exchange Commission (SEC) has approved its request to operate the first exchange AI-driven orde [...]
AI-Based Startup Optic Raises $11M to Put the ‘NF’ in NFTs
Founded in March, San Francisco-based Optic is developing an AI engine that processes the millions of new NFTs minted each day and compares the works [...]
3 / 3 POSTS